A trial looking at low dose cyclophosphamide for bowel cancer (BICCC)

This trial is looking at having cyclophosphamide chemotherapy. This is after completing treatment for bowel cancer.

It is for people who:

• were diagnosed with cancer that had grown into the lining of the bowel wall but had spread no further than to one other organ in the body. This is stage 2, stage 3 or stage 4A bowel cancer.

• had surgery with or without chemotherapy to treat their bowel cancer